Table 1 Demographic characteristics of study participants
Characteristics | Total n=82 |
|---|---|
Age | 41 (36–48) |
Race | Â |
   White | 28 (34%) |
   Black | 46 (56%) |
   Other | 8 (10%) |
Risk Factor | Â |
   Injection drug use | 11 (13%) |
   Endemic country | 27 (33%) |
   Heterosexual contact | 59 (72%) |
   Blood transfusion | 7 (9%) |
   Unknown | 8 (10%) |
Years since HIV diagnosis | 7 (3–11) |
CD4+ cell count prior to cART (μL) | 232 (128–400) |
Current CD4+ cell count (μL) | 487 (380–621) |
VL prior to cART (log10 copies/mL) | 4.5 (3.0-5.0) |
AIDS diagnosis | 19 (23%) |
Months since start of cART | 20 (9–45) |
cART includes PI | 47 (57%) |
cART includes NNRTI | 35 (43%) |
Missed ARV dose in past week | 6 (7%) |
Hepatitis B co-infection | 2 (2%) |
Hepatitis C co-infection | 10 (12%) |
Weight (kg) | 67.3 (60.3-81.5) |
BMI | 25.8 (22.4-31.3) |
Menstrual status | Â |
   Regular periods | 44 (54%) |
   Irregular periods | 10 (12%) |
   Current amenorrhea | 9 (11%) |
   Menopausal | 19 (23%) |